Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The heart failure burden of type 2 diabetes mellitus—a review of pathophysiology and interventions
Anne Pernille Ofstad, Dan Atar, Lars Gullestad, et al.
Heart Failure Reviews (2018) Vol. 23, Iss. 3, pp. 303-323
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes
Darren K. McGuire, Weichung Shih, Francesco Cosentino, et al.
JAMA Cardiology (2020) Vol. 6, Iss. 2, pp. 148-148
Open Access | Times Cited: 889
Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA
Darren K. McGuire, John H. Alexander, Odd Erik Johansen, et al.
Circulation (2019) Vol. 139, Iss. 3, pp. 351-361
Open Access | Times Cited: 148
Effect of SGLT2 Inhibitors on the Sympathetic Nervous System and Blood Pressure
André Scheen
Current Cardiology Reports (2019) Vol. 21, Iss. 8
Closed Access | Times Cited: 105
Sitagliptin, diabetes mellitus, and heart failure: an in-depth review of sitagliptin therapy and heart failure in patients with diabetes mellitus
Mohammadjavad Sotoudeheian, Seyed‐Mohamad‐Sadegh Mirahmadi, Pedram Salehi Darjani, et al.
Diabetology International (2025)
Closed Access | Times Cited: 1
Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits
Xiaowei Zhang, Zhiwei Zhang, Yajuan Yang, et al.
Cardiovascular Diabetology (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 55
Consensus recommendations for management of patients with type 2 diabetes mellitus and cardiovascular diseases
Alaaeldin Bashier, Azza Bin Hussain, Elamin Abdelgadir, et al.
Diabetology & Metabolic Syndrome (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 52
Vasodilatory Actions of Glucagon-Like Peptide 1 Are Preserved in Skeletal and Cardiac Muscle Microvasculature but Not in Conduit Artery in Obese Humans With Vascular Insulin Resistance
Nasui Wang, Alvin Wai Kit Tan, Linda A. Jahn, et al.
Diabetes Care (2019) Vol. 43, Iss. 3, pp. 634-642
Open Access | Times Cited: 48
High‐protein vs. standard‐protein diets in overweight and obese patients with heart failure and diabetes mellitus: findings of the Pro‐HEART trial
Lorraine S. Evangelista, Mini M. Jose, Hanaa S. Sallam, et al.
ESC Heart Failure (2021) Vol. 8, Iss. 2, pp. 1342-1348
Open Access | Times Cited: 31
Bexagliflozin on Renal Outcomes in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Marília Gobbo, Renan Yuji Ura Sudo, Tanize Milbradt, et al.
Cureus (2025)
Open Access
Allelic Discrimination of Vitamin D Receptor Polymorphisms and Risk of Type 2 Diabetes Mellitus: A Case-Controlled Study
Amal Ahmed Mohammed, Dina M. Abo El-Matty, Rola Abdel-Azeem, et al.
Healthcare (2023) Vol. 11, Iss. 4, pp. 485-485
Open Access | Times Cited: 9
A new nomogram to predict in-hospital mortality in patients with acute decompensated chronic heart failure and diabetes after 48 Hours of Intensive Care Unit
Linlin Liu, Lei Feng, Cheng Lü, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Thiazole-based and thiazolidine-based protein tyrosine phosphatase 1B inhibitors as potential anti-diabetes agents
Kexin Chen, Xu Yao, Ting Tang, et al.
Medicinal Chemistry Research (2020) Vol. 30, Iss. 3, pp. 519-534
Closed Access | Times Cited: 25
Vitamin D Receptor gene polymorphisms and susceptibility to type 2 diabetes: evidence from a meta-regression and meta-analysis based on 47 studies
A. Surendar, Mohammed Almasoody, Nihad Abdallah Selman, et al.
Journal of Diabetes & Metabolic Disorders (2021) Vol. 20, Iss. 1, pp. 845-867
Open Access | Times Cited: 23
L-Carnitine: An Antioxidant Remedy for the Survival of Cardiomyocytes under Hyperglycemic Condition
Fernanda Vacante, Pamela Senesi, A. Montesano, et al.
Journal of Diabetes Research (2018) Vol. 2018, pp. 1-12
Open Access | Times Cited: 24
Sodium-Glucose Co-transporter 2 Inhibitors in the Failing Heart: a Growing Potential
Dulce Brito, Paulo Bettencourt, Davide Carvalho, et al.
Cardiovascular Drugs and Therapy (2020) Vol. 34, Iss. 3, pp. 419-436
Open Access | Times Cited: 23
Glycaemic Variability and Hyperglycaemia as Prognostic Markers of Major Cardiovascular Events in Diabetic Patients Hospitalised in Cardiology Intensive Care Unit for Acute Heart Failure
Édouard Gerbaud, Ambroise Bouchard de la Poterie, Thomas Baudinet, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 6, pp. 1549-1549
Open Access | Times Cited: 11
Diabetes mellitus and congestive heart failure
Victoria Serhiyenko, A.A. Serhiyenko
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) (2022) Vol. 18, Iss. 1, pp. 57-69
Open Access | Times Cited: 11
Cardiovascular outcomes between dapagliflozin versus empagliflozin in patients with diabetes mellitus
J. J. Kim, Young‐Chae Yoon, Young‐Hoon Kim, et al.
Clinical Cardiology (2024) Vol. 47, Iss. 3
Open Access | Times Cited: 2
How Diabetes and Heart Failure Modulate Each Other and Condition Management
Varinder K. Randhawa, Savita Dhanvantari, Kim A. Connelly
Canadian Journal of Cardiology (2020) Vol. 37, Iss. 4, pp. 595-608
Closed Access | Times Cited: 16
Pathophysiology of Advanced Heart Failure
Jan Biegus, Piotr Niewiński, Krystian Josiak, et al.
Heart Failure Clinics (2021) Vol. 17, Iss. 4, pp. 519-531
Open Access | Times Cited: 15
A New Hope: Sodium-Glucose Cotransporter-2 Inhibition to Prevent Atrial Fibrillation
Nikolaos Karamichalakis, Vasileios Kolovos, Ioannis Paraskevaidis, et al.
Journal of Cardiovascular Development and Disease (2022) Vol. 9, Iss. 8, pp. 236-236
Open Access | Times Cited: 10
Series: Implications of the recent CVOTs in type 2 diabetes
André Scheen
Diabetes Research and Clinical Practice (2019) Vol. 159, pp. 107726-107726
Closed Access | Times Cited: 17
Heart failure and diabetes: role of ATM
Mary C. Wingard, Chad R. Frasier, Mahipal Singh, et al.
Current Opinion in Pharmacology (2020) Vol. 54, pp. 27-35
Open Access | Times Cited: 15
Diabetic patients need higher furosemide doses: a report on acute and chronic heart failure patients
Filipe Cunha, Joana Pereira, Pedro Marques, et al.
Journal of Cardiovascular Medicine (2019) Vol. 21, Iss. 1, pp. 21-26
Closed Access | Times Cited: 12
Integrated Bioinformatics Approach Showed Linagliptin as Potential Drug for Prevention of Cardiac Arrest and Cancer
Bhanupriya Dhabhai, Ramgopal Dhakar, Vipin Ranga, et al.
Deleted Journal (2023) Vol. 1, Iss. 3, pp. 131-141
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top